2-Aryl Imidazo[1,2-a]Pyridine-3-Acetamide Derivatives, Preparation Methods and Uses Thereof
申请人:Yang Rifang
公开号:US20130203754A1
公开(公告)日:2013-08-08
Disclosed are 2-arylimidazo[1,2-
a
]pyridine-3-acetamide derivatives represented by formula I, their tautomer, racemate or optical isomer, their pharmaceutically acceptable salt, or their solvates, wherein R
1
, R
2
, R
3
and R
4
are defined as in the specification. Preparation methods of said compounds and use of said compounds in treating and/or preventing central nervous system disease associated with TSPO functional disorder
2-ARYL IMIDAZO[1,2-A]PYRIDINE-3-ACETAMIDE DERIVATIVES, PREPARATION METHODS AND USE THEREOF
申请人:Institute Of Pharmacology And Toxicology Academy
Of Military Medical Sciences P.L.A. China
公开号:EP2586780B1
公开(公告)日:2017-03-22
US8980887B2
申请人:——
公开号:US8980887B2
公开(公告)日:2015-03-17
[EN] 2-ARYL IMIDAZO[1,2-A]PYRIDINE-3-ACETAMIDE DERIVATIVES, PREPARATION METHODS AND USE THEREOF<br/>[FR] DÉRIVÉS DU 2-ARYL IMIDAZO[1,2-?]PYRIDINE-3-ACÉTAMIDE, LEURS MÉTHODES DE PRÉPARATION ET UTILISATION
申请人:INST PHARM & TOXICOLOGY AMMS
公开号:WO2011160548A1
公开(公告)日:2011-12-29
Disclosed are 2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives represented by formula I, their tautomers, racemates or optical isomers, their pharmaceutically acceptable salts or their solvates, wherein R1, R2, R3 and R4 are defined as in the specification. Preparation methods of said compounds and use of said compounds in treating and/or preventing central nervous system diseases associated with TSPO functional disorders are also disclosed.